Papalamprakopoulou, Zoi
Ntagianta, Elisavet
Triantafyllou, Vasiliki
Kalamitsis, George
Dharia, Arpan
Dickerson, Suzanne S.
Hatzakis, Angelos
Talal, Andrew H.
Funding for this research was provided by:
Kaleida Health Foundation (Troup Fund)
Article History
Received: 28 March 2024
Accepted: 3 February 2025
First Online: 5 March 2025
Declarations
:
: The study protocol was approved by the Hellenic Scientific Society for the Study of AIDS, Sexually Transmitted and Emerging Diseases and the University at Buffalo Institutional Review Boards. The study adheres to the principles outlined in the Helsinki Declaration. We obtained written informed consent from all eligible participants prior to their participation and encouraged confidentiality among participants. Additionally, we reconsented participants verbally before the recording started, which was documented in the FGDs’ audio recording.
: Not applicable.
: A.T. received grants from Merck, Gilead, and Abbott Laboratories and has served as an advisor at Gilead. The remaining authors declare that they have no competing interests.